Syngen, Inc

SynGen, Inc is 10-year-old specialty DNA/RNA oligo synthesis company founded by two scientists who synthesized the very first commercial scale DNA oligo. The company has 4 patents and some proprietary process know-hows to position itself as the technology leader in DNA/RNA synthesis arena. SynGen Specialized in labeled and other modified DNA/RNA oligo synthesis. It's proprietary SR Technology platform enables production team to synthesize high purity crude oligos with exceptional yield and under room temperature. The SR Technology advantage is especially important in labeled DNA oligo and bulk DNA oligo production where crude quality and production yield are known to be low. Besides custom oligo synthesis, SynGen has a full line of specialty reagents for RNA/DNA synthesis, Among them, the Fmoc -protected DNA bases and neutral monomers are SynGen's patented molecules open up endless opportunities in new drug development and molecular diagnostic applications.